Skip to main content

Moxeza FDA Approval History

FDA Approved: Yes (First approved November 19, 2010)
Brand name: Moxeza
Generic name: moxifloxacin
Dosage form: Ophthalmic Solution
Company: Alcon, Inc.
Treatment for: Conjunctivitis, Bacterial

Moxeza (moxifloxacin hydrochloride ophthalmic solution) is a topical fluoroquinolone anti-infective indicated for the treatment of bacterial conjunctivitis.

Development timeline for Moxeza

Nov 19, 2010Approval FDA Approves Moxeza for Bacterial Conjunctivitis

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.